The parallel requirements for medical devices and pharmaceuticals are incorporated into this comprehensive webinar that delineates the foundation for technology transfer and validation, encompassing regulatory requirements and voluntary guidance.
The regulatory requirements for incorporation of technology transfer into validation and commercial production have evolved throughout the decades. The outputs from product/process development, including the identification of critical quality attributes and critical process parameters, should be clearly defined in a well-executed technology transfer program in order to develop a validation strategy that assures a successful product launch and conformance with safety, quality, potency, and purity and effectiveness requirements throughout the product lifecycle. Technology transfer is dependent on and defined by the type of product; therefore, a dedicated, product-specific plan is recommended. Example of the content of technology transfer plans will be provided in this training as well.
Why Should You Attend:
This webinar will discuss the concepts of technology transfer and validation as they relate to the commercial production of medical devices and pharmaceuticals. Research and development (R&D) activities are not regulated; however, the outputs from R&D serve as the launching pad for the manufacturing processes. Technology transfer is the term that applies to all the activities from the product and/or process development phases which serve as inputs to commercial manufacturing.The regulatory requirements for incorporation of technology transfer into validation and commercial production have evolved throughout the decades. The outputs from product/process development, including the identification of critical quality attributes and critical process parameters, should be clearly defined in a well-executed technology transfer program in order to develop a validation strategy that assures a successful product launch and conformance with safety, quality, potency, and purity and effectiveness requirements throughout the product lifecycle. Technology transfer is dependent on and defined by the type of product; therefore, a dedicated, product-specific plan is recommended. Example of the content of technology transfer plans will be provided in this training as well.
Learning Objectives:
- Key concepts for creating a model or program for technology transfer
- Incorporation of technology transfer into the validation strategy
- Process monitoring as evidence of maintaining the state of validation
Areas Covered in the Webinar:
- International regulatory requirements for technology transfer and validation
- Link between the development and validation phases
- Process design as input to the validation program
- Process performance as output from the validation program
- Process monitoring as a means to demonstrate the state of validation
Who Will Benefit:
This webinar will be of interest to professionals in early or middle phase in their careers in research and development, product development, manufacturing or validation in the pharmaceutical or medical device industries. Professionals interested in a refresher course on the concepts of technology transfer and validation will also benefit. Participants will include:- Quality Engineers
- Manufacturing Engineers
- Validation Engineers
- Validation Technicians
- R&D and Product Development Engineers and Scientists
Course Provider
Carlos Rodriguez Garcia,